Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Pfizer joins PD-1xVEGF race with $1.25B upfront to Chinese biotech 3SBio
5 days ago
Deals
Pharma
Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate
Last week
Pharma
Manufacturing
Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing
Last week
Financing
Pharma
Early bits of in vivo CAR-T human data emerge from biotech trials in China
3 weeks ago
R&D
Cell/Gene Tx
Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies
4 weeks ago
Pharma
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near
4 weeks ago
Pharma
Manufacturing
AstraZeneca posts another Truqap study fail, says China import tax could triple
4 weeks ago
Pharma
Law
WuXi AppTec sees growth after 2024 dip, plans ‘lean’ operations to temper ‘external opportunities’
4 weeks ago
Pharma
Manufacturing
Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval
5 weeks ago
R&D
Drugmakers see a substantial, but manageable, hit to business from tariffs. But the worst may lie ahead
5 weeks ago
Pharma
Thermo Fisher buckles up for US-China trade war, budgets $2B to ease impact
Last month
Pharma
Manufacturing
Merck’s Gardasil sales sink further amid China market pressure
Last month
Pharma
China’s biotech market is staging a comeback that US biotech can only wish for
Last month
Deals
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs
Last month
Pharma
Manufacturing
China startup injects CRISPR therapy into the brain for the first time
Last month
Startups
R&D
Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms
Last month
Startups
Deals
BioNTech-backed ADC maker DualityBio plans IPO on Hong Kong exchange
Last month
Financing
Startups
Amid Trump’s research cuts, commission says US risks losing biotech race without $15B investment
Last month
Pharma
ADC startup DualityBio seeks Hong Kong IPO amid precarious market
Last month
Financing
Startups
China's retaliatory tariffs on US could mean more headwinds for drugmakers
Last month
Pharma
Manufacturing
F-star management takes company private, two years after $161M cash exit to Sino's invoX
Last month
Deals
WuXi Biologics’ licensing deals help offset Biosecure threat in the US
2 months ago
Deals
Manufacturing
Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui
2 months ago
Deals
Pharma
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
2 months ago
R&D
Manufacturing
1
2
3
4
Next page
Last page
